Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0356 | 0.366 | 1 |
Echinococcus multilocularis | jun protein | 0.0438 | 0.4739 | 0.4739 |
Echinococcus granulosus | Ankyrin | 0.0078 | 0.0005 | 0.0005 |
Echinococcus granulosus | jun protein | 0.0438 | 0.4739 | 0.4739 |
Brugia malayi | hypothetical protein | 0.0344 | 0.3502 | 0.739 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0078 | 0.0005 | 0.0013 |
Loa Loa (eye worm) | hypothetical protein | 0.0426 | 0.4581 | 1 |
Schistosoma mansoni | jun-related protein | 0.0356 | 0.366 | 1 |
Echinococcus multilocularis | Ankyrin | 0.0078 | 0.0005 | 0.0005 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0838 | 1 | 1 |
Onchocerca volvulus | 0.0344 | 0.3502 | 0.5 | |
Brugia malayi | bZIP transcription factor family protein | 0.0438 | 0.4739 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0438 | 0.4739 | 0.4739 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0438 | 0.4739 | 0.4739 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.